• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核磁共振代谢组学揭示鞘氨醇激酶-1是癌细胞异常代谢表型调控中的一个新分子开关。

NMR metabolomics highlights sphingosine kinase-1 as a new molecular switch in the orchestration of aberrant metabolic phenotype in cancer cells.

作者信息

Bernacchioni Caterina, Ghini Veronica, Cencetti Francesca, Japtok Lukasz, Donati Chiara, Bruni Paola, Turano Paola

机构信息

Department of Biomedical, Clinical and Experimental Sciences, University of Florence, Italy.

CERM and Department of Chemistry, University of Florence, Italy.

出版信息

Mol Oncol. 2017 May;11(5):517-533. doi: 10.1002/1878-0261.12048. Epub 2017 Mar 30.

DOI:10.1002/1878-0261.12048
PMID:28258651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5527469/
Abstract

Strong experimental evidence in animal and cellular models supports a pivotal role of sphingosine kinase-1 (SK1) in oncogenesis. In many human cancers, SK1 levels are upregulated and these increases are linked to poor prognosis in patients. Here, by employing untargeted NMR-based metabolomic profiling combined with functional validations, we report the crucial role of SK1 in the metabolic shift known as the Warburg effect in A2780 ovarian cancer cells. Indeed, expression of SK1 induced a high glycolytic rate, characterized by increased levels of lactate along with increased expression of the proton/monocarboxylate symporter MCT1, and decreased oxidative metabolism, associated with the accumulation of intermediates of the tricarboxylic acid cycle and reduction in CO production. Additionally, SK1-expressing cells displayed a significant increase in glucose uptake paralleled by GLUT3 transporter upregulation. The role of SK1 is not limited to the induction of aerobic glycolysis, affecting metabolic pathways that appear to support the biosynthesis of macromolecules. These findings highlight the role of SK1 signaling axis in cancer metabolic reprogramming, pointing out innovative strategies for cancer therapies.

摘要

动物和细胞模型中的有力实验证据支持鞘氨醇激酶-1(SK1)在肿瘤发生中起关键作用。在许多人类癌症中,SK1水平上调,且这些升高与患者预后不良相关。在此,通过采用基于非靶向核磁共振的代谢组学分析并结合功能验证,我们报告了SK1在A2780卵巢癌细胞中被称为瓦伯格效应的代谢转变中的关键作用。事实上,SK1的表达诱导了高糖酵解速率,其特征是乳酸水平升高以及质子/单羧酸转运体MCT1的表达增加,同时氧化代谢降低,这与三羧酸循环中间产物的积累和CO产生减少有关。此外,表达SK1的细胞葡萄糖摄取显著增加,同时GLUT3转运体上调。SK1的作用不仅限于诱导有氧糖酵解,还影响似乎支持大分子生物合成的代谢途径。这些发现突出了SK1信号轴在癌症代谢重编程中的作用,为癌症治疗指出了创新策略。

相似文献

1
NMR metabolomics highlights sphingosine kinase-1 as a new molecular switch in the orchestration of aberrant metabolic phenotype in cancer cells.核磁共振代谢组学揭示鞘氨醇激酶-1是癌细胞异常代谢表型调控中的一个新分子开关。
Mol Oncol. 2017 May;11(5):517-533. doi: 10.1002/1878-0261.12048. Epub 2017 Mar 30.
2
CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1.CIB2 通过鞘氨醇激酶 1 负调控卵巢癌细胞中的致癌信号。
Cancer Res. 2017 Sep 15;77(18):4823-4834. doi: 10.1158/0008-5472.CAN-17-0025. Epub 2017 Jul 20.
3
Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.基因调控网络揭示了溶血磷脂酸诱导卵巢癌细胞代谢适应的分子线索。
Mol Oncol. 2017 May;11(5):491-516. doi: 10.1002/1878-0261.12046. Epub 2017 Apr 3.
4
Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models.ARHI(DIRAS3)诱导自噬改变了卵巢癌模型中的基本代谢途径。
BMC Cancer. 2016 Oct 26;16(1):824. doi: 10.1186/s12885-016-2850-8.
5
Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.卵巢癌进展过程中的代谢变化及其作为神经酰胺治疗靶点的研究进展。
Exp Cell Res. 2013 Jun 10;319(10):1431-42. doi: 10.1016/j.yexcr.2013.02.017. Epub 2013 Mar 19.
6
Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.雄激素反应性和非反应性前列腺癌细胞呈现出明显不同的糖酵解代谢特征。
Int J Biochem Cell Biol. 2012 Nov;44(11):2077-84. doi: 10.1016/j.biocel.2012.08.013. Epub 2012 Aug 16.
7
Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.1-磷酸鞘氨醇受体、鞘氨醇激酶和鞘氨醇在癌症与炎症中的作用
Adv Biol Regul. 2016 Jan;60:151-159. doi: 10.1016/j.jbior.2015.09.001. Epub 2015 Sep 25.
8
De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.鞘氨醇激酶1在哺乳动物细胞中从头生物合成二氢神经酰胺-1-磷酸。
Cell Signal. 2006 Oct;18(10):1779-92. doi: 10.1016/j.cellsig.2006.01.018. Epub 2006 Mar 10.
9
Sphingosine kinase 1 is up-regulated in colon carcinogenesis.鞘氨醇激酶1在结肠癌发生过程中上调。
FASEB J. 2006 Feb;20(2):386-8. doi: 10.1096/fj.05-4331fje. Epub 2005 Nov 30.
10
Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation.丝氨酸剥夺时需要下调鞘氨醇激酶 1 以适应环境。
FASEB J. 2021 Feb;35(2):e21284. doi: 10.1096/fj.202001814RR.

引用本文的文献

1
NMR Metabolomics of Primary Ovarian Cancer Cells in Comparison to Established Cisplatin-Resistant and -Sensitive Cell Lines.原发性卵巢癌细胞的 NMR 代谢组学与已建立的顺铂耐药和敏感细胞系的比较。
Cells. 2024 Apr 9;13(8):661. doi: 10.3390/cells13080661.
2
Research progress on the mechanism of glycolysis in ovarian cancer.卵巢癌糖酵解机制的研究进展。
Front Immunol. 2023 Nov 28;14:1284853. doi: 10.3389/fimmu.2023.1284853. eCollection 2023.
3
LncRNA MAFG-AS1 is involved in human cancer progression.长链非编码 RNA MAFG-AS1 参与人类癌症进展。

本文引用的文献

1
Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia.鞘氨醇-1-磷酸促进红细胞糖酵解和氧气释放以适应高原缺氧。
Nat Commun. 2016 Jul 15;7:12086. doi: 10.1038/ncomms12086.
2
Recent advances in the development of sphingosine kinase inhibitors.鞘氨醇激酶抑制剂开发的最新进展。
Cell Signal. 2016 Sep;28(9):1349-1363. doi: 10.1016/j.cellsig.2016.06.007. Epub 2016 Jun 11.
3
Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor.天冬酰胺通过作为氨基酸交换因子来促进癌细胞增殖。
Eur J Med Res. 2023 Nov 8;28(1):497. doi: 10.1186/s40001-023-01486-9.
4
Highly Charged Ru(II) Polypyridyl Complexes as Photosensitizer Agents in Photodynamic Therapy of Epithelial Ovarian Cancer Cells.荷正电钌(II)多吡啶配合物作为光动力疗法中上皮性卵巢癌细胞光敏剂的应用。
Int J Mol Sci. 2022 Nov 1;23(21):13302. doi: 10.3390/ijms232113302.
5
Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy.卵巢癌肿瘤免疫微环境的代谢重编程:免疫治疗的新方向。
Front Immunol. 2022 Oct 14;13:1030831. doi: 10.3389/fimmu.2022.1030831. eCollection 2022.
6
Sphingosine 1-phosphate attenuates neuronal dysfunction induced by amyloid-β oligomers through endocytic internalization of NMDA receptors.鞘氨醇 1-磷酸通过内吞作用内化 NMDA 受体来减轻淀粉样β寡聚物诱导的神经元功能障碍。
FEBS J. 2023 Jan;290(1):112-133. doi: 10.1111/febs.16579. Epub 2022 Aug 12.
7
S1P Signalling Axis Is Necessary for Adiponectin-Directed Regulation of Electrophysiological Properties and Oxidative Metabolism in C2C12 Myotubes.S1P 信号轴对于脂联素指导的 C2C12 肌管电生理特性和氧化代谢的调节是必要的。
Cells. 2022 Feb 17;11(4):713. doi: 10.3390/cells11040713.
8
Role of Sphingosine 1-Phosphate Signalling Axis in Muscle Atrophy Induced by TNFα in C2C12 Myotubes.Sphingosine 1-Phosphate 信号轴在 TNFα诱导的 C2C12 肌管萎缩中的作用。
Int J Mol Sci. 2021 Jan 28;22(3):1280. doi: 10.3390/ijms22031280.
9
Differential Network Analysis Reveals Molecular Determinants Associated with Blood Pressure and Heart Rate in Healthy Subjects.差异网络分析揭示了与健康受试者血压和心率相关的分子决定因素。
J Proteome Res. 2021 Jan 1;20(1):1040-1051. doi: 10.1021/acs.jproteome.0c00882. Epub 2020 Dec 4.
10
Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer.代谢组学评估非小细胞肺癌患者对免疫检查点抑制剂的反应
Cancers (Basel). 2020 Nov 30;12(12):3574. doi: 10.3390/cancers12123574.
Nat Commun. 2016 Apr 29;7:11457. doi: 10.1038/ncomms11457.
4
Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances.鞘氨醇 1-磷酸和鞘氨醇激酶在健康和疾病中的作用:最新进展。
Prog Lipid Res. 2016 Apr;62:93-106. doi: 10.1016/j.plipres.2016.03.001. Epub 2016 Mar 10.
5
A sphingolipid mechanism for behavioral extinction.一种行为消退的鞘脂机制。
J Neurochem. 2016 May;137(4):589-603. doi: 10.1111/jnc.13537. Epub 2016 Mar 15.
6
Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.鞘氨醇激酶1是子宫颈癌的一个可靠预后因素及新型治疗靶点。
Oncotarget. 2015 Sep 29;6(29):26746-56. doi: 10.18632/oncotarget.4818.
7
MCT1 promotes the cisplatin-resistance by antagonizing Fas in epithelial ovarian cancer.在卵巢上皮癌中,单羧酸转运蛋白1通过拮抗Fas来促进顺铂耐药。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):2710-8. eCollection 2015.
8
Sphingosine 1-phosphate counteracts insulin signaling in pancreatic β-cells via the sphingosine 1-phosphate receptor subtype 2.1-磷酸鞘氨醇通过1-磷酸鞘氨醇受体2亚型抵消胰腺β细胞中的胰岛素信号传导。
FASEB J. 2015 Aug;29(8):3357-69. doi: 10.1096/fj.14-263194. Epub 2015 Apr 24.
9
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy.重新审视鞘脂变阻器:癌症治疗中的不断演变的概念。
Exp Cell Res. 2015 May 1;333(2):195-200. doi: 10.1016/j.yexcr.2015.02.025. Epub 2015 Mar 11.
10
Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer.异常 O-糖基化蛋白:乳腺癌和结直肠癌的新视角。
Front Endocrinol (Lausanne). 2014 Nov 11;5:193. doi: 10.3389/fendo.2014.00193. eCollection 2014.